September 18, 2018
Formulary update scheduled for October 1, 2018
Formulary updates generally take place twice yearly in response to changes in the drug marketplace. The updates happening as of October 1 affect all Commercial segments (including large group, small group and individual segments). This update does not affect Medicare programs.
This formulary update includes the following:
- Brand drugs that have lost patent protection and are now available with generic equivalents
- Select drugs removed from coverage through the Pharmacy & Therapeutics Committee review process
- Drugs that do not meet eligibility requirements (i.e. non-FDA approved or OTC drugs)
- Select generic drugs that require a higher copay
For these changes, 2,033 members across the Commercial market segment received notification letters by September 1.
Click here for a complete list of the October 1 formulary changes.